Pharmacy Technician Certification Exams — PTCE With Online Test Pharmacy Technician Certification Exam
1. How many prefilled 5 mL oral syringes must be dispensed to provide a 72 hour supply?
Answer: C
24 prefilled 5 mL oral syringes must be dispensed to provide a 72 hour supply.
To provide a 72 hour supply, a total of 24 prefilled 5 mL oral syringes must be dispensed, as this quantity ensures that the required dosage is met over the specified time period.
A) 6
This option is incorrect because dispensing 6 syringes would only provide a total of 30 mL (6 syringes x 5 mL each), which is insufficient for a 72 hour supply. The total amount required is greater than what 6 syringes can provide.
B) 12
Dispensing 12 syringes would yield 60 mL (12 syringes x 5 mL each), which still falls short of the required amount for 72 hours. Therefore, this option is also incorrect as it does not meet the necessary dosage.
C) 24
This is the correct option because dispensing 24 syringes provides a total of 120 mL (24 syringes x 5 mL each). This amount is adequate to cover the required treatment over 72 hours.
D) 36
While dispensing 36 syringes would provide 180 mL (36 syringes x 5 mL each), it exceeds the required supply for 72 hours. Hence, this option is incorrect as it provides more medication than necessary.
Conclusion
The correct answer is 24 prefilled 5 mL oral syringes, as this quantity meets the required dosage for a 72 hour supply. All other options either provide insufficient medication or exceed the necessary amount, confirming that they do not satisfy the requirements of the question.
Answer: C
It would be most appropriate for the pharmacy technician to first transfer the patient's call to a pharmacist.
Transferring the patient's call to a pharmacist is the best first step, as pharmacists are trained to assess medication issues, including discrepancies in appearance and potential safety concerns. The pharmacist can provide the patient with the necessary guidance and determine if further action is needed.
A) suggest that the patient notify their prescriber.
While notifying the prescriber may ultimately be necessary, it is not the most immediate action the pharmacy technician should take. The technician may not have the expertise to evaluate the issue; thus, they should first refer the patient to a pharmacist who can assess the situation appropriately.
B) refer the patient to the drug manufacturer.
Referring the patient to the drug manufacturer is not advisable as a first step. This option could delay addressing the patient's concerns and does not provide immediate assistance or information regarding the medication's safety or efficacy. The pharmacy should handle such inquiries internally first.
C) transfer the patient's call to a pharmacist.
This is the correct option as it ensures that a qualified professional evaluates the patient's concern regarding the discrepancy in medication appearance. The pharmacist can perform the necessary checks on the medication and advise the patient on the next steps, including whether the medication is safe to use.
D) instruct the patient to return the medication to the pharmacy.
Instructing the patient to return the medication may be a necessary step later, but it should not be the first action taken. Without a proper evaluation of the situation by a pharmacist, asking the patient to return the medication does not address their immediate concerns or ensure their safety.
Conclusion
Transferring the call to a pharmacist is crucial because it allows for a professional assessment of the medication issue, which ensures patient safety and proper handling of potential medication errors. The other options either delay necessary actions or are not appropriate as initial responses to the patient’s concern. Thus, Option C is the most suitable first response in this scenario.
Answer: B
Gowns worn during the preparation of hazardous nonsterile compounds must be selected based on the specific hazardous drugs being handled.
Selecting gowns based on the specific hazardous drugs being handled ensures that the protective equipment is appropriate for the level of risk associated with those drugs, thereby enhancing safety during compounding procedures.
A) have seams or closures that could allow hazardous drugs to reach the skin
This option is incorrect because gowns designed for handling hazardous compounds must be constructed to prevent hazardous drugs from reaching the skin. Seams or closures that could allow such exposure would contradict safety protocols outlined in USP Chapter 800.
B) be selected based on the specific hazardous drugs being handled
This option is correct as it emphasizes the importance of tailoring protective gowns to the specific properties and risks of the hazardous drugs involved. This practice is crucial for ensuring adequate protection against exposure.
C) be made of reusable material to absorb hazardous drug residue
This option is incorrect because while gowns may be made of reusable materials, the primary concern is not absorption but rather impermeability to hazardous substances. Gowns should prevent any hazardous drug exposure, rather than absorb residues.
D) have short sleeves and open cuffs to minimize hazardous drug exposure
This option is incorrect because short sleeves and open cuffs would actually increase the risk of exposure to hazardous drugs, contrary to the protective measures recommended by USP Chapter 800. Long sleeves and closed cuffs are essential for minimizing skin exposure.
Conclusion
The correct answer is definitive because selecting gowns based on the specific hazardous drugs being handled aligns with the safety protocols established in USP Chapter 800. All other options fail to meet the necessary standards for protection against hazardous drug exposure, either by promoting inadequate gown design or by misunderstanding the purpose of protective equipment.
4. Therapeutic duplication may be a concern for a patient prescribed both trazodone and:
Answer: C
Therapeutic duplication may be a concern for a patient prescribed both trazodone and nortriptyline.
Therapeutic duplication is a significant concern when a patient is prescribed both trazodone and nortriptyline, as both medications are antidepressants that can increase the risk of serotonin syndrome and other adverse effects when used concurrently.
A) nabumetone.
Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and does not have overlapping therapeutic effects with trazodone. Therefore, there is no concern for therapeutic duplication when these two medications are prescribed together.
B) nystatin.
Nystatin is an antifungal medication primarily used to treat fungal infections. It does not share any pharmacological properties with trazodone, which means that there is no risk of therapeutic duplication between these two drugs.
C) nortriptyline.
Nortriptyline is a tricyclic antidepressant that acts similarly to trazodone, both being used to treat depression and anxiety disorders. The concurrent use of these medications raises the risk of enhanced side effects, including sedation and serotonin syndrome, thus representing a clear case of therapeutic duplication.
D) nicardipine.
Nicardipine is a calcium channel blocker used primarily for hypertension and angina. It does not have similar therapeutic effects to trazodone, so there is no issue of therapeutic duplication when combined with trazodone.
Conclusion
The identification of nortriptyline as the correct answer highlights the importance of monitoring for therapeutic duplication when prescribing medications with similar pharmacological effects. In contrast, nabumetone, nystatin, and nicardipine do not pose this risk, as they function in entirely different therapeutic categories, making them safe to prescribe alongside trazodone.
Answer: A
Any medication error that was captured and corrected prior to reaching the patient may be reported as a Near miss.
A near miss refers to a situation where a medication error was identified and rectified before it could harm the patient. This concept emphasizes the importance of proactive measures in healthcare settings to prevent potential patient harm.
A) Near miss
This option is correct as it accurately describes an error that was intercepted before it reached the patient. Near misses are critical for learning and improving processes to enhance patient safety.
B) Adverse event
An adverse event refers to an injury resulting from medical management rather than the underlying condition of the patient. Since the error was corrected before it reached the patient, it does not qualify as an adverse event.
C) Sentinel event
A sentinel event is an unexpected occurrence involving death or serious physical or psychological injury. As the error was caught before affecting the patient, it does not fit the definition of a sentinel event.
D) Unauthorized drug
An unauthorized drug is one that has not been approved for use or is not prescribed to the patient. This option does not apply to the context of an error that was corrected prior to patient interaction.
Conclusion
The correct classification of a medication error that is corrected before reaching the patient is a near miss, as it highlights the preventive actions taken to protect patient safety. Other options, such as adverse events, sentinel events, and unauthorized drugs, do not pertain to errors that were successfully intercepted, thus reinforcing the importance of identifying and learning from near misses in healthcare practice.
6. Oral preparation in sweetened alcohol vehicle =
Answer: D
Oral preparation in sweetened alcohol vehicle is an elixir.
An elixir is defined as a clear, sweetened hydroalcoholic solution used for medicinal purposes, making it the correct choice when describing an oral preparation in a sweetened alcohol vehicle.
A) emulsion
An emulsion is a mixture of two immiscible liquids, typically oil and water, stabilized by an emulsifier. This does not apply to a sweetened alcohol vehicle, as emulsions do not involve alcohol as a primary component or sweetening agent.
B) syrup
A syrup is a concentrated solution of sugar in water, which may or may not contain medicinal substances. While syrups are sweetened, they do not typically involve alcohol, thus disqualifying them from being classified as an oral preparation in a sweetened alcohol vehicle.
C) solution
A solution is a homogeneous mixture of two or more substances, but it does not specifically denote the presence of alcohol or sweetness. Therefore, while a solution could potentially be sweetened, it does not specifically refer to an alcoholic preparation, making it an incorrect choice.
D) elixir
An elixir is specifically a type of solution that contains alcohol and is sweetened, fitting the definition of an oral preparation in sweetened alcohol vehicle perfectly. Elixirs are often used to dissolve both water-soluble and alcohol-soluble components, making them suitable for medicinal formulations.
Conclusion
The correct answer, elixir, accurately describes an oral preparation that combines alcohol and sweetness, aligning with the characteristics outlined in the question. In contrast, the other options—emulsion, syrup, and solution—fail to meet the specific criteria of containing both a sweetened alcohol vehicle and the intended medicinal properties.
7. Controlled substance Rx records kept for:
Answer: B
Controlled substance Rx records must be kept for 2 years.
Controlled substance prescription records are required to be maintained for a period of 2 years in compliance with regulatory standards. This timeframe ensures that adequate records are available for review and auditing purposes.
A) 1 year
Maintaining controlled substance Rx records for only 1 year is insufficient and does not comply with legal requirements. Regulatory guidelines explicitly state a longer retention period to ensure proper tracking and accountability.
B) 2 years
Keeping controlled substance Rx records for 2 years is the correct duration as stipulated by regulatory authorities. This period allows for sufficient oversight and minimizes the risk of misuse or diversion of controlled substances.
C) 3 years
Storing controlled substance Rx records for 3 years exceeds the mandated requirement and is unnecessary. While longer retention may seem beneficial, it does not align with the established regulations, which specifically dictate a 2-year period.
D) 4 years
Similar to option C, retaining records for 4 years is not compliant with the regulations governing controlled substances. The legal framework specifies a maximum of 2 years for record retention to streamline administrative processes and ensure efficiency.
Conclusion
The correct retention period for controlled substance Rx records is 2 years, as outlined by regulatory standards. Other options, including 1, 3, and 4 years, do not meet the compliance requirements and could lead to potential legal issues for practitioners. Thus, option B is definitively the most appropriate choice.
8. A Class I recall is one in which the product in question:
Answer: D
A Class I recall may cause serious adverse health consequences or death.
A Class I recall is issued when there is a reasonable probability that the use of or exposure to the recalled product will cause serious adverse health consequences or even result in death.
A) is not likely to cause serious adverse health consequences
This option is incorrect as it describes a situation that would not warrant a Class I recall. Class I recalls are specifically for products that are likely to cause serious health risks, not those that are deemed safe.
B) causes no health concerns whatsoever
This choice is also incorrect because a Class I recall pertains to products that indeed pose significant health risks. A product that causes no health concerns would not necessitate a recall classification of this severity.
C) causes temporary or medically reversible adverse health consequences or a very remote probability of serious health consequences
While this option describes a situation that could lead to a recall, it better fits a Class II recall rather than a Class I. Class I recalls involve serious health risks, not merely reversible or negligible ones.
D) may cause serious adverse health consequences or death
This option correctly defines a Class I recall. It captures the essence of the classification, indicating that the product in question poses a serious risk to health that could potentially lead to severe outcomes, including death.
Conclusion
The correct answer, D, accurately reflects the critical nature of a Class I recall, emphasizing the potential for serious health consequences or death. The other options fail to recognize the severity and implications associated with this classification, thereby distinguishing D as the only appropriate choice.
9. Which of the following insulins may be administered intravenously as well as subcutaneously?
Answer: A
Regular insulin may be administered intravenously as well as subcutaneously.
Regular insulin is the only insulin formulation that can be safely and effectively administered both intravenously and subcutaneously, making it suitable for situations requiring rapid control of blood glucose levels.
A) Regular
Regular insulin is designed for both subcutaneous and intravenous administration, allowing for flexibility in treatment, particularly in acute care settings. Its pharmacokinetic profile supports quick action, which is critical when managing patients in emergencies.
B) NPH
NPH (Neutral Protamine Hagedorn) insulin is an intermediate-acting insulin that is not suitable for intravenous use. It is formulated for subcutaneous administration due to its slower onset and prolonged action, making it inappropriate for rapid glycemic control via IV.
C) 70/30
70/30 insulin, a combination of 70% NPH and 30% regular insulin, is primarily intended for subcutaneous use. The presence of NPH in this mixture limits its suitability for intravenous administration, as the NPH component cannot be given IV.
D) Glargine
Glargine insulin is a long-acting insulin that is specifically formulated for subcutaneous use only. Its pharmacological properties prevent it from being utilized intravenously, as it is designed to provide a steady release of insulin over a prolonged period.
Conclusion
Regular insulin is distinctly the only option that can be administered both intravenously and subcutaneously, making it essential for immediate blood glucose management. The other options, NPH, 70/30, and Glargine, are not suitable for intravenous use due to their formulation and pharmacokinetics, thus confirming that Regular insulin is the correct choice.
Answer: C
Sertraline is the most likely substitute for escitalopram.
Sertraline is an antidepressant that belongs to the same class of drugs as escitalopram, which is a selective serotonin reuptake inhibitor (SSRI). Therefore, it is often considered a suitable alternative when escitalopram is not available or appropriate for a patient.
A) Cabergoline
Cabergoline is a dopamine agonist primarily used to treat conditions like hyperprolactinemia. It does not share the same pharmacological properties or indications as escitalopram, making it an unsuitable substitute for treating depression or anxiety disorders.
B) Ciprofloxacin
Ciprofloxacin is an antibiotic used to treat various bacterial infections. It has no relation to the treatment of psychiatric conditions or mood disorders, thus cannot be considered a substitute for escitalopram.
C) Sertraline
Sertraline is a selective serotonin reuptake inhibitor (SSRI), just like escitalopram. It is commonly prescribed for similar indications, such as major depressive disorder and anxiety disorders, making it the most appropriate substitute when escitalopram is unavailable.
D) Amantadine
Amantadine is primarily used as an antiviral medication and to treat Parkinson's disease. It does not have the same mechanism of action as escitalopram and is not indicated for depression or anxiety, rendering it an ineffective substitute.
Conclusion
Sertraline stands out as the most fitting substitute for escitalopram due to its classification as an SSRI and its efficacy in treating similar mood disorders. In contrast, the other options—cabergoline, ciprofloxacin, and amantadine—are unrelated to the treatment of depression and are therefore not suitable alternatives.